Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Breast Cancer Screening and Timing of Breast MRI-Experience in a Genetic High-Risk Screening Clinic in a Comprehensive Cancer Center.

Current oncology (Toronto, Ont.) - 19 Mar 2022

Wang Xia, Chang Maxine D, Lee Marie Catherine, Niell Bethany L

Abstract excerpt

For women with genetic risk of breast cancer, the addition of screening breast MRI to mammography has become a standard. The order and interval of annual imaging can be variable among providers. To evaluate the clinical implications related to the timing, we conducted a chart review on a cohort of women (N = 276) with high-risk (BRCA1, BRCA2, CDH1, PTEN and TP53) and moderate high-risk (ATM and CHEK2)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 35323371
DOI: 10.3390/curroncol29030171
PMCID: PMC8947675

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Breast Cancer Screening and Timing of Breast MRI-Experience in a Genetic High-Risk Screening Clinic in a Comprehensive Cancer Center.PMID 35323371Read ↗

Screening for hereditary breast cancer.Semantic proximity Read ↗

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Semantic proximity Read ↗

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.Semantic proximity Read ↗

The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations.Semantic proximity Read ↗

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.Semantic proximity Read ↗

Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study.Semantic proximity Read ↗

Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.Semantic proximity Read ↗

BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.Semantic proximity Read ↗

First experiences in screening women at high risk for breast cancer with MR imaging.Semantic proximity Read ↗

The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.Semantic proximity Read ↗

MRI screening in a clinic population with a family history of breast cancer.Semantic proximity Read ↗

Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.